Annals of Diagnostic Pathology
Volume 14, Issue 3 , Pages 204-208, June 2010

Oncocytic adrenocortical carcinoma

  • Hiroya Ohtake, MD, PhD

      Affiliations

    • Department of Pathology, Yamagata University School of Medicine, Yamagata 990-9585, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 23 628 5238; fax: +81 23 628 5240.
  • ,
  • Hiroshi Kawamura, MD, PhD

      Affiliations

    • Division of Surgery, Sanyudo Hospital, Yonezawa 992-0045, Japan
  • ,
  • Masami Matsuzaki, MD, PhD

      Affiliations

    • Division of Surgery, Hoshi General Hospital, Koriyama 963-8501, Japan
  • ,
  • Eiichi Yokoyama, MD

      Affiliations

    • Division of Surgery, Sanyudo Hospital, Yonezawa 992-0045, Japan
  • ,
  • Masayuki Kitajima, MD

      Affiliations

    • Division of Urology, Saiseikai Kurihashi Hospital, Kurihashi 349-1105, Japan
  • ,
  • Shiro Onizuka, MD, PhD

      Affiliations

    • Division of Urology, Tokyo Women's Medical University, Tokyo 162-8666, Japan
  • ,
  • Mitsunori Yamakawa, MD, PhD

      Affiliations

    • Department of Pathology, Yamagata University School of Medicine, Yamagata 990-9585, Japan

published online 09 September 2009.

Abstract 

Only 17 cases of oncocytic adrenocortical carcinoma have been reported in the English literature. Here, we report an incidental case of oncocytic adrenocortical carcinoma. The patient was a 69-year-old man with the chief complaint of abdominal pain. Abdominal computed tomography revealed a left adrenal tumor. No hormonal symptoms were observed. The excised tumor was whitish, encapsulated, and 75 × 60 × 45 mm in size. Large polygonal tumor cells were arranged in a generally diffuse architecture and exhibited abundant eosinophilic granular cytoplasm. Nuclear atypia with atypical mitotic figures and capsular and sinusoidal invasions were observed. The tumor cells were immunopositive for vimentin, neuron-specific enolase, and synaptophysin but not for α-inhibin, melan A, or p53. Diffuse and strong immunopositivity with an antimitochondrial antibody proved that this tumor was truly oncocytic. Upon review of previous cases of oncocytic adrenocortical tumors, we reconsidered the diagnostic findings of the potential for malignancy.

Keywords: Adrenal gland, Oncocytic adrenocortical carcinoma, Bisceglia's criteria, Immunohistochemistry

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1092-9134(09)00080-X

doi:10.1016/j.anndiagpath.2009.06.006

Annals of Diagnostic Pathology
Volume 14, Issue 3 , Pages 204-208, June 2010